Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Anna R. Yousaf"'
Autor:
Ashutosh Wadhwa, Sherry Yin, Brandi Freeman, Rebecca B Hershow, Marie Killerby, Anna R Yousaf, Sandra Lester, Lisa Mills, Sean A Buono, Mary Pomeroy, Daniel Owusu, Victoria T Chu, Jacqueline E Tate, Sanjib Bhattacharyya, Patricia Hall, Natalie J Thornburg, Hannah L Kirking
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255208 (2021)
Serologic assays developed for SARS-CoV-2 detect different antibody subtypes and are based on different target antigens. Comparison of the performance of a SARS-CoV-2 Spike-Protein ELISA and the nucleocapsid-based Abbott ArchitectTM SARS-CoV-2 IgG as
Externí odkaz:
https://doaj.org/article/ac55392967704b4081817d90f55189e9
Autor:
Ethan R. Bornstein, Allison D. Miller, Laura D. Zambrano, Anna R. Yousaf, Andria Apostolou, Thomas Weiser, Angela P. Campbell
Publikováno v:
Pediatric Infectious Disease Journal. 42:e105-e108
Autor:
Anna R. Yousaf, Amber Kunkel, Joseph Y. Abrams, Ami B. Shah, Teresa A. Hammett, Kathryn E. Arnold, Yajira L. Beltran, Federico R. Laham, Carol M. Kao, David A. Hunstad, Laila Hussaini, Nadine Baida, Luis Salazar, Maria A. Perez, Christina A. Rostad, Shana Godfred-Cato, Angela P. Campbell, Ermias D. Belay
Publikováno v:
Pediatric Infectious Disease Journal. 42:252-259
Autor:
Michael Melgar, Ellen H. Lee, Allison D. Miller, Sarah Lim, Catherine M. Brown, Anna R. Yousaf, Laura D. Zambrano, Ermias D. Belay, Shana Godfred-Cato, Joseph Y. Abrams, Matthew E. Oster, Angela P. Campbell
Publikováno v:
MMWR. Recommendations and Reports. 71:1-14
regarding identification of MIS-C and its distinction from other pediatric conditions, a review of available literature comparing MIS-C phenotype with that of pediatric COVID-19 and other hyperinflammatory syndromes, and retrospective application of
Autor:
Allison D Miller, Anna R Yousaf, Ethan Bornstein, Michael J Wu, Katherine Lindsey, Michael Melgar, Matthew E Oster, Laura D Zambrano, Angela P Campbell
Publikováno v:
Clinical Infectious Diseases. 75:S303-S307
We describe 2116 multisystem inflammatory syndrome in children (MIS-C) cases reported to the Centers for Disease Control and Prevention during Delta and Omicron circulation from July 2021 through January 2022. Half of MIS-C patients were aged 5–11
Autor:
Margaret M Cortese, Allan W Taylor, Lara J Akinbami, Andrea Thames-Allen, Anna R Yousaf, Angela P Campbell, Susan A Maloney, Theresa A Harrington, E Gloria Anyalechi, Datta Munshi, Satoshi Kamidani, C Robinette Curtis, David W McCormick, Mary A Staat, Kathryn M Edwards, C Buddy Creech, Oidda Museru, Paige Marquez, Deborah Thompson, John R Su, Elizabeth P Schlaudecker, Karen R Broder
Publikováno v:
The Journal of Infectious Diseases.
Multisystem inflammatory syndrome in children (MIS-C) is a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; in the United States, reporting of MIS-C after coronavirus disease 2019 (COVID-19) vaccination is requi
Autor:
Anna R Yousaf, Allison D Miller, Katherine Lindsey, Michael J Wu, Michael Melgar, Laura D Zambrano, Angela P Campbell
Publikováno v:
Open Forum Infectious Diseases. 9
Background CDC began collecting COVID-19 vaccination status of persons with MIS-C as part of national surveillance in May, 2021. We describe and compare MIS-C in fully vaccinated persons with MIS-C in persons with partial or no vaccination reported.
Autor:
Anne M. Hause, David K. Shay, Nicola P. Klein, Winston E. Abara, James Baggs, Margaret M. Cortese, Bruce Fireman, Julianne Gee, Jason M. Glanz, Kristin Goddard, Kayla E. Hanson, Brandon Hugueley, Tat’Yana Kenigsberg, Elyse O. Kharbanda, Bruno Lewin, Ned Lewis, Paige Marquez, Tanya Myers, Allison Naleway, Jennifer C. Nelson, John R. Su, Deborah Thompson, Babatunde Olubajo, Matthew E. Oster, Eric S. Weintraub, Joshua T.B. Williams, Anna R. Yousaf, Ousseny Zerbo, Bicheng Zhang, Tom T. Shimabukuro
Publikováno v:
Pediatrics
BACKGROUND AND OBJECTIVES Limited postauthorization safety data for the Pfizer-BioNTech coronavirus disease 2019 vaccination among children ages 5 to 11 years are available, particularly for the adverse event myocarditis, which has been detected in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d720eaa8a2f2faabeb7b0d7d391276
https://europepmc.org/articles/PMC9706403/
https://europepmc.org/articles/PMC9706403/
Autor:
Kimberly Christensen, Elizabeth A. Dietrich, Anna R Yousaf, Almea Matanock, Sanjib Bhattacharyya, Daniel Owusu, Angela Dunn, Natalie J. Thornburg, Victoria T Chu, Brett Whitaker, Ian W Pray, Ashutosh Wadhwa, Mary Pomeroy, Tair Kiphibane, Nathaniel M. Lewis, Aron J. Hall, Sarah Willardson, Hannah L Kirking, Ryan P Westergaard, Trivikram Dasu, Jacqueline E. Tate
Publikováno v:
The Journal of Infectious Diseases
Background To better understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding and infectivity, we estimated SARS-CoV-2 RNA shedding duration, described participant characteristics associated with the first negative rRT-PCR tes
Autor:
Mark Fajans, Allison Binder, Hannah E. Reses, Natalie J. Thornburg, Michelle Banks, Ian W Pray, Brandi Freeman, Angela Dunn, Almea Matanock, Tair Kiphibane, Sherry Yin, Sanjib Bhattacharyya, Katherine A. Battey, Lisa A. Mills, Hannah L Kirking, Daniel Owusu, Anna R Yousaf, Cuc H. Tran, Radhika Gharpure, Erin E. Conners, Victoria T Chu, Lucia C. Pawloski, Aron J. Hall, Henry Njuguna, Patrick Dawson, Sean A Buono, Ryan P Westergaard, Jeni Vuong, Christopher J. Gregory, Michelle O'Hegarty, Jared R. Rispens, Sarah Willardson, Susan I. Gerber, Nathaniel M. Lewis, Elizabeth A. Dietrich, Rebecca J Chancey, Kim Christensen, Lindsey Page, Lindsey M. Duca, Ashutosh Wadhwa, Scott A Nabity, Perrine Marcenac, Ann Christiansen, John C. Watson, Amy C Schumacher, Phillip P. Salvatore, Rebecca L. Laws, Elizabeth M Rabold, Victoria L. Fields, Eric Pevzner, Garrett Fox, Dongni Ye, Jacqueline E. Tate, Mary Pomeroy, Trivikram Dasu, Sandra Lester
Publikováno v:
Clinical Infectious Diseases. 73:e1805-e1813
Background The evidence base for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is nascent. We sought to characterize SARS-CoV-2 transmission within US households and estimate the household secondary infection rate (SIR) to inform strat